2021.09.21

Genomtec® receives notice of allowance on the granting of its patent by the Japan Patent Office

Company has has received a notice of allowance from the Japan Patent Office (JPO) granting the Company patent protection for the Genomtec®ID ...
2021.08.25

Genomtec has filed a patent application for a set of primers for detecting Salmonella enterica infections, one of the most common infectious diseases among humans and animals

Company has filed a patent application for a proprietary primer set, diagnostic method and reaction mixture composition for genetic diagnosis of ...
2021.08.16

Genomtec intends to move to the Main Market of the Warsaw Stock Exchange (WSE)

Genomtec S.A. has expressed its intention to seek a transfer of the Company’s listing from the alternative stock exchange of NewConnect to ...
2021.08.12

Genomtec’s flagship solution enters critical development phase. Company summarizes second quarter activities

Genomtec S.A. has published a report for the second quarter of 2021 containing financial results and a summary of the most important activities ...
2021.08.06

Genomtec receives ISO 13485 certification completing another essential step in the Genomtec ID project

Genomtec SA has been certified in accordance to ISO 13485 standard for its quality management system compliance via audits carried out by TÜV ...
2021.07.26

Global experts on the Genomtec Scientific Advisory Board

The Company has appointed a Scientific Advisory Board consisting of global experts in healthcare systems management and technology. The ...